Cadomed Pharmaceuticals India Private Limited, a active private limited company, was established on 02 March 2011 in Mysuru, Karnataka, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74900KA2011PTC057327. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 70 professional, Its leadership includes Carmal Asha (Director), Vinodkumar Surendrababu (Director), Shobha Shambunahalli Mariswamigowda (Director). It holds ₹7.60 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.18, Ground Floor, 1St Cross, 2Nd Stage, Gangothri Layout, Mysuru, Karnataka, 570009.
U74900KA2011PTC057327
057327
02 March 2011
₹1.00 M
₹1.00 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Cadomed Pharmaceuticals India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Carmal Asha | Director | 02 Mar 2011 | Current |
| Vinodkumar Surendrababu | Director | 02 Mar 2011 | Current |
| Shobha Shambunahalli Mariswamigowda | Director | 02 Mar 2011 | Current |
| Deepak Kumar Nanjegowda | Director | 02 Mar 2011 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cadomed Pharmaceuticals India Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.74% increase. The company also saw a substantial improvement in profitability, with a 137.13% increase in profit. The company's net worth moved up by a moderate rise of 2.35%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Cadomed Pharmaceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹7,603,565.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Oct 2025 | Hdfc Bank Limited | ₹3.77 M | Open |
| 12 Apr 2021 | Hdfc Bank Limited | ₹3.83 M | Open |
Explore comprehensive loan charge details -
Cadomed Pharmaceuticals India has a workforce of 70 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cadomed Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cadomed Pharmaceuticals India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Hdfc Bank Limited amounted to Rs. 3.77 M with Charge ID 101195058 was registered on 29 Oct 2025. was completed.
The activity Cadomed Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Cadomed Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 3.83 M with Charge ID 100442261 was registered on 12 Apr 2021. was recorded as a recent event.
Carmal Asha was appointed as a Director was appointed as a Director on 02 Mar 2011 & has been associated with this company since 14 years 9 months . was recorded as a recent event.
Progress on Vinodkumar Surendrababu was appointed as a Director was appointed as a Director on 02 Mar 2011 & has been associated with this company since 14 years 9 months . was documented.
The CIN of Cadomed Pharmaceuticals India Private Limited is U74900KA2011PTC057327.
Cadomed Pharmaceuticals India Private Limited is headquartered at No.18, Ground Floor, 1St Cross, 2Nd Stage, Gangothri Layout, Mysuru, Karnataka, 570009.
Cadomed Pharmaceuticals India Private Limited was incorporated on 02 March 2011.
The current directors of Cadomed Pharmaceuticals India Private Limited are
The primary industry of Cadomed Pharmaceuticals India Private Limited is Trade.
Cadomed Pharmaceuticals India Private Limited is unlisted.
The authorized capital of Cadomed Pharmaceuticals India Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Cadomed Pharmaceuticals India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX